Dáil Éireann Debate, Tuesday - 12 July 2022
987. Deputy Colm Burke asked the Minister for Health if his Department has examined international best practice such as those in Scotland and Germany on the matter of interim and early access reimbursement models; and if he will make a statement on the matter. [37823/22]
View answerI can confirm that interim and early access reimbursement models have been examined. The HSE and the Department would not support a pathway enabling reimbursement in the Irish context while further clinical evidence and data is collected on a given medicine.
The HSE and NCPE advise that such a pathway would rest on the assumption that the collected data would support a positive reimbursement recommendation, which is often not the case.
